References
- Jeong HY, Kim H, Kwon S, et al. Evaluation of the GenoType(R) MTBDRsl assay in Korean patients with MDR or XDR tuberculosis. Infect Dis (Lond). 2016;48:361–366.
- World Health Organization. WHO Global Tuberculosis Report 2016; 2016 [Internet]. Available from: http://www.who.int/tb/publications/global_report/en/.
- Aung HL, Tun T, Moradigaravand D, et al. Whole-genome sequencing of multidrug-resistant Mycobacterium tuberculosis isolates from Myanmar. J Glob Antimicrob Resist. 2016;6:113–117.
- Nyunt WW, Aung ST, Lwin T, et al. First- and second-line antituberculosis drug resistance patterns among previous treatment failure patients in Myanmar. J Glob Antimicrob Resist. 2017;9:34–35.
- Huang WL, Chi TL, Wu MH, et al. Performance assessment of the GenoType MTBDRsl test and DNA sequencing for detection of second-line and ethambutol drug resistance among patients infected with multidrug-resistant Mycobacterium tuberculosis. J Clin Microbiol. 2011;49:2502–2508.
- Casali N, Nikolayevskyy V, Balabanova Y, et al. Evolution and transmission of drug-resistant tuberculosis in a Russian population. Nat Genet. 2014;46:279–286.
- Lee AS, Othman SN, Ho YM, et al. Novel mutations within the embB gene in ethambutol-susceptible clinical isolates of Mycobacterium tuberculosis. Antimicrob Agents Chemother. 2004;48:4447–4449.